ABAD inhibitors - Evaluation of novel compounds as potential new therapies for Alzheimer’s disease

Project: Standard

Project Details

AcronymABAD inhibitors - Evaluation of novel
StatusFinished
Effective start/end date1/04/2331/01/24

Funding

  • Medical Research Council: £32,536.77